Kirtland Capital Partners has sold MicroGroup to TE Connectivity
Lincoln International (“Lincoln”), a leading global mid-market investment bank, is pleased to announce that Kirtland Capital Partners (“Kirtland”) and other shareholders have sold MicroGroup, Inc. (“MicroGroup” or the “Company”) to TE Connectivity Ltd. (“TE”). Terms of the transaction were not disclosed.
MicroGroup is a leading manufacturer of precision medical components and sub-assemblies with expertise in difficult-to-manufacture, small diameter stainless steel tubing. The Company offers a comprehensive, integrated suite of 50+ in-house precision metal production operations supporting the full product life cycle from prototype to production. MicroGroup’s customers include more than half of the world’s largest medical device and analytical instrument companies across analytical and diagnostic instruments, cardiology, gastroenterology and endoscopy, neurology and spinal, and orthopedic and sports medicine segments. MicroGroup was founded in 1971 and is headquartered in Medway, Massachusetts. For more information, visit www.microgroup.com.
Bill Bergen, President and CEO of MicroGroup, commented, “Lincoln’s medical device outsourcing experience and insights were key to positioning MicroGroup’s unique business model and value proposition in a compelling manner.”
Tom Littman, President and Managing Partner of Kirtland, also noted, “Lincoln faithfully represented Kirtland and other shareholders by driving a strategic outcome through senior level attention, buyer knowledge and relationships, and process excellence.”
Lincoln acted as the exclusive investment banking representative for Kirtland and MicroGroup, working closely with the Company’s management team and shareholders throughout the sale process. The transaction closed less than three months from when Lincoln started the marketing process, delivering a strategic outcome on an accelerated timeline. Lincoln provided advisory expertise and managed the preparatory, marketing, negotiation and due diligence phases of the transaction.
About Kirtland Capital Partners
Kirtland Capital Partners is a lower mid-market private equity firm with 40 years of experience partnering with management teams to create long-term value. The firm pursues a flexible investment approach, making both majority and minority equity investments in companies throughout the United States and Canada. Throughout its history, Kirtland has successfully invested in a wide variety of niche manufacturing and business services companies. Kirtland focuses on building long-term partnerships with its management teams, investors, operating resources, service providers, and financing and deal sources. Relationships matter at Kirtland.
Meet our Senior Team
I work hand in hand with clients to help drive business improvements and strategic positioning.
View More Transactions
Lincoln International is pleased to announce the successful sale of C³ (Cannabinoid Compound Company), a subsidiary of Bionorica SE, a producer and marketer of cannabis-based therapeutic compounds, to Canopy Growth
Lincoln is pleased to announce that it has advised Riello Investimenti SGR on the sale of Trafimet Group to Kemppi Oy
Lincoln International is pleased to have advised Tikehau Capital on its £23 million minority investment into Medtrade, a UK based manufacturer of advanced woundcare and consumer healthcare products
Lincoln International is pleased to announce the successful completion of a $20 million Series C financing round for Rapid Medical